EML empowers pharmaceutical brands to create authentic experiences and communicate effectively with professionals, patients and stakeholders. It builds connections by combining 360° campaigns and experiential activations to advance the sector’s evolution. Over 25 years, EML has partnered with more than 90 pharmaceutical companies and 300 clients across 13 countries. Campaigns are delivered in multiple languages and adapted to local cultures, shaping how health information is shared, understood and acted upon. Clear and impactful communication turns knowledge into strategies that build trust and improve health outcomes. “More than a marketing agency, we see ourselves as a strategic partner in the evolution of the health industry,” says Eliana Pedraza, Innovation Manager. Strategic partnership matters as the healthcare industry faces increasing complexity. Strict regulations and evolving digital channels demand communication that reaches diverse audiences without losing scientific accuracy. EML meets this challenge by designing campaigns that are compliant and capable of sparking connections that inspire meaningful action and deliver measurable results. “Personalization drives every engagement. Each project begins with a rigorous discovery process that clarifies client needs, brand identity, and market conditions. Every initiative aligns with the client’s goals while addressing the distinct context of the brand,” says Juan Camilo Martínez, Healthcare Strategy Director. Technology integration amplifies the agency’s impact. EML was among the first to incorporate platforms like Veeva and IQVIA into pharmaceutical marketing strategies. These tools allow campaigns to deliver modular content tailored to specific audiences. They also support ethical engagement with physicians, helping clients build trust while optimizing marketing investments. The platforms help EML deliver timely, relevant information that supports clinical decisions and boosts campaign results....Read more